1. Ayer, J.G., Harmer, J.A., Nakhla, S., Xuan, W., Ng, M.K., Raitakari, O.T., Marks, G.B. and Celermajer, D.S.(2009) HDL-Cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arterioscler Thromb Vasc Biol. 29(6):943-949. 2. Ayer, J.G., Harmer, J.A., Xuan, W., Toelle, B., Webb, K., Almqvist, C., Marks, G.B. and Celermajer, D.S. (2009) Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: effects on blood pressure and arterial structure and function at age 8 years. Am J Clin Nutr. 90(2): 438-446. 3. Baker, A.R., Harte, A.L., Pritlove, D.C., da Silva, N.F., Youssef, E.M., Khunti, K., Davies, M.J., Kumar, S., Pagano, D. and McTernan, P.G. (2009) Epicardial adipose tissue as a source of NF{kappa}B and JNK mediated inflammation in patients with coronary artery disease. J Clin Endocrinol Metab. 94(1):261-267. 4. Barter, P.J. (2009) Lessons learned from the investigation of lipid level management to its impact in atherosclerotic events. (ILLUMINATE) trial. Am J Cardiol 104 (suppl 10) 10e-15E. 5. Bergman, A.J., Cote, J., Maes, A., Zhao, J.J., Roadcap, B.A., Sun, L., Valesky, R.J., Yang, A., Keymeulen, B., Mathijs, Z., De Smet, M., Laethem, T., Davies, M.J., Wagner, J.A. and Herman, G.A. (2009) Effect of sitagliptin on the pharmacokinetics of simvastatin. J Clin Pharmacol. 49(4):483-488. 6. Cannon, C.P., Dansky, H.M., Davidson, M., Gotto, A.M. Jr, Brinton, E.A., Gould, A.L., Stepanavage, M., Liu, S.X., Shah, S., Rubino, J., Gibbons, P., Hermanowski-Vosatka, A., Bintowitz, B., Mitchel, Y. and Barter, P;DEFINE investigators.(2009) Design of DEFINE trial: determining the efficancy and tolerability of CETP inhibition with Anacetrapib. Am Heart J. 158(4): 513-519. e3. 7. Carmel, J.F., Tarnus, E., Cohn, J.S., Bourdon, E., Davignon, J. and Bernier, L. (2009) High expression of apolipoprotein E impairs lipid storage and promotes cell proliferation in human adipocytes. J Cell Biochem.106(4):608-617. 8. Chan, D.C., Lambert, G., Hugh, P., Barrett, B., Rye, K.A., Ooi, E.M.M. and Watts, G.E.(2009) Plasma proprotein convertase subtilisin/kexin type 9: a marker of LDL apolipoprotein B-100 Catabolism. Clin Chem. 55(11): 2049-2052. 9. Chan, D.C., Watts, G.F., Ooi, E.M., Rye, K.A., Ji, J., Johnson, A.G. and Barrett, P.H.(2009) Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolics syndrome. Diabetes Care. 32(11): 2111-2113. 10. Chapman, A.L., Skaff, O., Senthilmohan, R., Kettle, A.J. and Davies, M.J.(2009) Hypobromous acid and bromamine production by neutrophils and modulation by superoxide. Biochem J. 417(3): 773-781. 11. Chirovsky, D.R., Fedirko, V., Cui, Y., Sazonov, V. and Barter, P.J.(2009) Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review. Eur J Cardiovasc Prev Rehabil. 16(4): 404-423. 12. Celermajer, D.S. and Chow, C.K. (2009) Concerning an Oversight. Atherosclerosis. 204(2):352. 13. Davis, J.S., Yeo, T.W., Thomas, J.H., McMillian, M., Darcy, C.J., McNiel, Y.R., Cheng, A.C., Celermajer, D.S., Stephens, D.P. and Anstey, N.M. (2009) Sepsis-associated microvascular dysfunction measured by peripheral arterial tonometry: an observational study. Crit Care. 13(5): R155. 14. Davies, M.J. (2009) Electron paramagnetic resonance detection of radicals in biology and medicine, in Electron Paramagnetic Resounce, Brustolon, M. and Giamello, E. eds. Hoboken, NJ. Wiley. 425-448. 15. Dunlop, R.A., Brunk, U.T. and Rodgers, K.J.(2009) Oxidized proteins: mechanisms of removal and consequences of accumulation. IUBMB Life. 61(5):522-527. 16. Fryirs, M., Barter, P.J. and Rye, K.A.(2009) Cholesterol metabolism and pancreatic beta-cell function. Curr Opin Lipidol. 20(3):159-164. 17. Graves, L.E., Hennessy, A., Sunderland, N.S., Heffernan, S.J. and Thomson, S.E. (2009) Incidence of lymphoma in a captive-bred colony of hamadryas baboons (Papio hamadryas). Aust Vet 87, (6) 238-243. 18. Groover, S.A., Kaouache, M., Joseph, L., Barter, P. and Davignon, J. (2009) Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels. Arch Intern Med 169 (19), 1775-1780. 19. Gracanin, M., Hawkins, C.L., Pattison, D.I. and Davies, M.J.(2009) Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products. Free Radic Biol Med. 47(1):92-102. 20. Hawkins, C.L. (2009) Role of hypothiocyanous acid (HOSCN) in biological systems. Free Rad Res 43 (12), 1147-1158. 21. Hawkins, C.L., Morgan, P.E. and Davies, M.J. (2009) Quantification of protein modification by oxidants. Free Rad Biol Med. 46; 965-988. 22. Hawkins, C.L., Pattison, D.I., Stanley, N.R. and Davies, M.J. (2009) Tryptophan residues are targets in hypothiocyanous acid-mediated protein oxidation. Biochem J. 416(3): 441-452. 23. Ilsar, R., Chawantanpipat, C., Chan, K.H., Waugh, R., Hennessy, A., Celermajer, D.S. and Ng, M.K.(2009) The measurement of pulmonary flow researve in high order primates. Clin Exp Pharmacol Physiol. 36(8): 797-802. 24. Kennett, E.C. and Davies, M.J.(2009) Glycosaminoglycans are fragmented by hydroxyl, carbonate, and nitrogen dioxide radicals in a site-selective manner:Implications for peroxynitrite-mediated damage at sites of inflammation. Free Radic Biol Med. 47(4): 389-400. 25. Kyia, Y., Miura, S.I., Imaizumi, S., Uehara, Y., Matsuo, Y., Abe, S., Jimi, S., Urata, H., Rye, K.A. and Saku, K. (2009) Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats. Atherosclerosis. 203(1):137-144. 26. Lam, M.A., Pattison, D.I., Bottle, S.E., Keddie, D.J. and Davies, M.J. (2009) Nitric oxide and nitroxides can get as efficient scavangers of protein-derived free radicals. Chem Res Toxiol. 21(11):2111-2119. 27. Lambert, G., Charlton, F., Rye, K.A. and Piper, D.E.(2009) Molecular basis of PCSK9 function. Atherosclerosis. 203(1):1-7. 28. Laurila, P.P., Naukkarinen, J., Kristiansson, K., Ripatti, S., Kauttu, T., Silander, K., Salomaa, V., Perola, M., Karhunen, P.J., Barter, P.J., Ehnholm, C. and Peltonen, L. (2009) Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol 30 (2), 346-352. 29. Ling, H., Waterworth, D.M., Stirnadel, H.A., Pollin, T.I., Barter, P.J., Kesaniemi, Y.A., Mahley, R.W., McPherson, R., Waeber, G, Bersot, T.P., Cohen, J.C., Grundy, S.M., Mooser, V.E. and Mitchell, B.D.(2009) Genome-wide linkage and association analysis to identify genes influencing adiponectin levels: The GEMS Study. Obesity (Silver Spring). 17(4): 737-744. 30. Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Galic, S., Shields, B.J., Ooms, L.M., Stepto, N., Wu, B., Mitchell, C.A., Tonks, N.K., Watt, M.J., Febbraio, M.A., Crack, P.J., Andrikopoulos, S. and Tiganos, T. (2009) Reactive oxygen species enhance insulin sensitivity. Cell Metab 10 (4), 260-272. 31. Maple-Brown, L.J., Cunningham, J., Barry, R.E., Leylsey, L., O'Rourke, M.F., Celermajer, D.S. and O'Dea, K. (2009) Impact of dyslipidaemia on arterial structure and function in urban indigenous Australians. Atherosclerosis. 202(1): 248-254. 32. Marijon, E., Celermajer, D.S., Tafflet, M., El-Haou, S., Jani, D.N., Ferreira, B., Mocumbi, A.O., Paquet, C., Sidi, D. and Jouven, X. (2009) Rheumatic heart disease screening by echocardiography. The inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation. 120(8): 663-668. 33. McGrath, K.C., Li, X.H., Puranik, R., Liong, E.C., Tan, J.T., Dy, V.M., Di Bartolo, B.,Barter, P.J., Rye, K.A. and Heather, A.K.(2009) Role of 3{beta}-Hydroxysteroid-{Delta}24 reductase in mediating anti-inflammatory effects of high-density lipoproteins in endothelial cells. Arterioscler Thromb Vasc Biol. 29(6): 877-882. 34. McRobb, L., Handelsman, D.J. and Heather, A.K.(2009) Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology. 150(2):841-848. 35. Morgan, P.E., Sturgess, A.D. and Davies, M.J. (2009) Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res. 43(2): 117-127. 36. Ng, M.K., Liu, P.Y., Williams, A.J., Nakhla, S., Ly, L.P., Handelsman, D.J. and Celermajer, D.S.(2009) Prospective study of effect of androgens on serum inflammatory markers in men. Arterioscler Thromb Vasc Biol. 22(7): 1136-1141. 37. Peshavariya, H., Dusting, G.L., Di Bartolo, B., Rye, K.A., Barter, P.J. and Jiang, F. (2009) Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase by activation by disrupting lipid rafts. Free Radic Res. 43(8): 772-782. 38. Patel, S., Drew, B.G., Nakhla, S., Duffy, S.J., Murphy, A.J., Barter, P.J., Rye, K.A., Chin-Dusting, J., Hoang, A., Sviridov, D.,Celermajer, D.C. and Kingwell, B.A. (2009) Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. J Am Coll Cardiol. 53(11):962-971. 39. Patel, S., Puranik, R., Nakhla, S., Lundman, P., Stocker, R., Wang, X.S, Lambert, G., Rye, K.A., Barter, P.J., Nicholls, S.J. and Celermajer, D.S. (2009) Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high-density lipoproteins. Atherosclerosis. 204(2): 424-428. 40. Rees, M.D., Bottle, S.E., Fairfull-Smith, K.E., Malle, E., Whitelock, J.M. and Davies, M.J. (2009) Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides. Biochem J. 421(1): 79-86. 41. Pattison, D.I., Hawkins, C.L. and Davies, M.J. (2009) What are the plasma targets of oxidant hypochlorous acid? A kinetic modeling approach. Chem Res Toxicol. 22(5): 8007-817. 42. Rodgers, K.J., Ford, J.L. and Brunk U.T.(2009) Heat Shock proteins: keys to healthy ageing? Redox Rep. 14(4): 147-153. 43. Royle, C., Lim, S., Xu, B., Tooher, j., Ogle, R. and Hennessy, A. (2009) Effect of hypoxia and exogenous lL-10 on the pro-inflammatory cytokine TNF-alpha and the anti-atherogenic molecule soluble Flt-1 in placental villous explants. Cytokine 47(1): 56-60. 44. Rye, K.A., Bursill, C.A., Lambert, G., Tabet, F. and Barter, P.J. (2009) The metabolism and anti-atherogenic properties of HDL. J Lipid Res (50) S195-200. Abstract Unavailable. 45. Schwartz, G.G, Olsson, A.G., Balantyne, C.M., Barter, P.J., Holme, I.M., Kallend, D., Leiter, L.A., Leitersdorf, E., McMurray, J.J., Shah, P.K., Tardiff, J.C., Chaitman, B.R., Duttlinger-Maddux, J: dal-OUTCOMES Committees and Investigators (2009) Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heat J. 158(6): 896-901. 46. Seki, E., De Minicis, S., Gwak, G.Y., Kluwe, J., Inokuchi, S., Bursill, C.A., Llovet, J.M, Brenner, D.A. and Schwabe, R.F. (2009) CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 19, (7) 1858-1870. 47. Skaff, O., Pattison, D.I. and Davies, M.J.(2009) Hypothiocyanous acid reactivity with low-molecular-mass and protein thiols: Absolute rate constants and assessment of biological relevance. Biochem J. 422(1): 111-117. 48. Strychar, I., Cohn, J.S., Renier, G., Rivard, M., Aris-Jilwan, N., Beauregard, H., Meltzer, S., Belanger, A., Dumas, R., Ishac, A., Radwan, F. and Yale, J.F. (2009) Effects of a higher-carbohydrate/lower-fat diet versus a lower-carbohydrate/higher-fat-monounsaturated diet on postmeal triglyceride concentrations and other cardiovascular risk factors in Type 1 Diabetes. Diabetes Care. 32(9): 1597-1599. 49. Tabet, F. and Rye, K.A. (2009) High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond). 116(2): 87-98. 50. Tabet, F., Remaley, A.T., Segaliny, A.I., Millet, J., Yan, L., Nakhla, S., Barter, P.J., Rye, K.A. and Lambert, G. (2009) The 5A apolipoprotein A-I mimetic peptide displays anti-inflammatory and anti-oxidant properties in vivo and in vitro. Arterioscler Thromb Vasc Biol 30, (2) 246-252. 51. Tandy, S., Chung, R.W., Wate, E., Kamili, A., Berge, K., Griinari, M. and Cohn, J.S.(2009) Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high fat fed mice. J Agric Food Chem. 57(19): 9339-9345. 52. Taskinen, M.R., Sullivan, D.R., Ehnholm, C., Whiting, M., Zannino, D, Simes, R.J., Keech, A.C. and Barter, P.J.; for the FIELD study investigators(2009) Relationships of HDL Cholesterol, ApoA-I and ApoA-II with homocysteine and creatinine in patients with type 2 Diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol. 29(6): 950-955. 53. Wat, E., Tandy, S., Kapera, E., Kamili, A., Chung, R.W., Brown, A., Rowney, M. and Cohn, J.S.(2009) Dietary phospholipid-rich dairy milk reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis. 205(1): 144-150. 54. Wu, B.J., Midwinter, R.G., Cassano, C., Beck, K., Wang, Y., Changsiri, D., Gamble, J.R. and Stocker, R. (2009) Heme oxygenase-1 increases endothelial progenitor cells. Arterioscler Thromb Vasc Biol 29 (10), 1537-1542. 55. Xu, B., Thornton, C., Tooher, J., Ogle, R., Lim, S., Makris, A. and Hennessy, A.(2009) Anti-hypertensive drugs effect on SFLT-1 and sendoglin production from human normal and preeclamptic placentas in-vitro. Clin Exp Pharmacol Physiol. 36(8): 839-842. 56. Xu, B., Thornton, C., Tooher, J. and Hennessy, A. (2009) Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1/Th2 cytokine production from normal placental explants via intracellular calcium. Hypertens Pregnancy 28 (4), 448-456. 57. Yeo, T.W., Lampah, D.A., Tjitra, E., Gitawati, R., Kenangalem, E., Piera, K., Granger, D.L., Lopansri, B.K., Weinberg, J.B., Price, R.N., Duffull, S.B., Celermajer, D.S. and Anstey, N.M.(2009) Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis. 200(10):1522-1529. 58. Zerrad-Saadi, A., Therond, P., Chantepie, S., Couturier, M, Rye, K.A., Chapman, M.J. and Kontush, A.(2009) HDL 3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity. Relevance to inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol. 29(12):2169-2175.
Continue to previous years publications